Evidence map›Paper›PMID 30371753›Full record

Observational studyClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017.

Fiona P Havers, Jessie R Chung, Edward A Belongia, Huong Q McLean, Manjusha Gaglani, Kempapura Murthy, Richard K Zimmerman, Mary Patricia Nowalk, Michael L Jackson, Lisa A Jackson and 4 more

Abstract readObservational Study
In one paragraph

Observational study in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Evaluating the Impact of Statin Use on Influenza Vaccine Effectiveness and Influenza Infection in Older Adults.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  6. Review
  7. Review
  8. Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 1 country.

Fiona P HaversCenters for Disease Control and Prevention, Atlanta, Georgia.
Jessie R ChungCenters for Disease Control and Prevention, Atlanta, Georgia.
Edward A BelongiaMarshfield Clinic Research Institute, Wisconsin.
Huong Q McLeanMarshfield Clinic Research Institute, Wisconsin.
Manjusha GaglaniBaylor Scott and White Health.
Kempapura MurthyBaylor Scott and White Health.
Richard K ZimmermanUniversity of Pittsburgh, Pennsylvania.
Mary Patricia NowalkUniversity of Pittsburgh, Pennsylvania.
Michael L JacksonKaiser Permanente Washington Health Research Institute, Seattle.
Lisa A JacksonKaiser Permanente Washington Health Research Institute, Seattle.
Arnold S MontoUniversity of Michigan School of Public Health, Ann Arbor.
Joshua G PetrieUniversity of Michigan School of Public Health, Ann Arbor.
Alicia M FryCenters for Disease Control and Prevention, Atlanta, Georgia.
Brendan FlanneryCenters for Disease Control and Prevention, Atlanta, Georgia.
Centers for Disease Control and Prevention · USKaiser Permanente Washington Health Research Institute · USMarshfield Clinic · USUniversity of Michigan–Ann Arbor · USUniversity of Pittsburgh · USBaylor Scott & White Health · USTexas A&M University · US

Funding

UNIVERSITY OF PITTSBURGH CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE: BPCAUL1RR024153 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$73.9M
University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
Annual Estimates of Influenza Vaccine Effectiveness and Evaluation of Immune Response in a Wisconsin PopulationU01IP001038 · IP · MARSHFIELD CLINIC RESEARCH FOUNDATION · PI BELONGIA, EDWARD · 2016 to 2020
$8.0M
Prospective annual estimates of influenza vaccine effectiveness and burden of diseaseU01IP001037 · IP · KAISER FOUNDATION RESEARCH INSTITUTE · PI JACKSON, MICHAEL L · 2016 to 2020
$7.8M
Outpatient VE for seasonal flu, pandemic flu and RSV in a large, diverse networkU01IP001035 · IP · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZIMMERMAN, RICHARD K · 2016 to 2020
$7.8M
Mandatory_Estimates of Vaccine Effectiveness Against Medically-Attended, PCR-Confirmed Influenza in West South Central U.S.U01IP001039 · IP · SCOTT AND WHITE MEMORIAL HOSPITAL · PI GAGLANI, MANJUSHA · 2016 to 2020
$6.5M
Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness ResearchU01IP000474 · IP · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MONTO, ARNOLD S · 2011 to 2015
$6.2M
Core_plus Option_A_C_Influenza Surveillance and Vaccine Effectiveness in a LargeU01IP000467 · IP · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZIMMERMAN, RICHARD K · 2011 to 2015
$5.9M
Core_plus Option_B_C_Influenza Vaccine Effectiveness in a Wisconsin PopulationU01IP000471 · IP · MARSHFIELD CLINIC RESEARCH FOUNDATION · PI BELONGIA, EDWARD · 2011 to 2015
$5.6M
Core_Prospective population-based estimation of influenza vaccine effectiveness aU01IP000466 · IP · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI JACKSON, MICHAEL L · 2011 to 2015
$4.1M
Core_RT-PCR based Case-Control: Apt Measure of Influenza Vaccine EffectivenessU01IP000473 · IP · SCOTT AND WHITE MEMORIAL HOSPITAL · PI GAGLANI, MANJUSHA · 2011 to 2015
$4.0M
NCATS NIH HHS UL1 TR000005NCIRD CDC HHS U01 IP000466NCIRD CDC HHS U01 IP000467NCIRD CDC HHS U01 IP000471NCIRD CDC HHS U01 IP000473NCIRD CDC HHS U01 IP000474NCIRD CDC HHS U01 IP001034NCIRD CDC HHS U01 IP001035NCIRD CDC HHS U01 IP001037NCIRD CDC HHS U01 IP001038NCIRD CDC HHS U01 IP001039NCRR NIH HHS UL1 RR024153
6 · The paper itself

Abstract

backgroundStatin medications have immunomodulatory effects. Several recent studies suggest that statins may reduce influenza vaccine response and reduce influenza vaccine effectiveness (VE).

methodsWe compared influenza VE in statin users and nonusers aged ≥45 years enrolled in the US Vaccine Effectiveness Network study over 6 influenza seasons (2011-2012 through 2016-2017). All enrollees presented to outpatients clinics with acute respiratory illness and were tested for influenza. Information on vaccination status, medical history, and statin use at the time of vaccination were collected by medical and pharmacy records. Using a test-negative design, we estimated VE as (1 - OR) × 100, in which OR is the odds ratio for testing positive for influenza virus among vaccinated vs unvaccinated participants.

resultsAmong 11692 eligible participants, 3359 (30%) were statin users and 2806 (24%) tested positive for influenza virus infection; 78% of statin users and 60% of nonusers had received influenza vaccine. After adjusting for potential confounders, influenza VE was 36% (95% confidence interval [CI], 22%-47%) among statin users and 39% (95% CI, 32%-45%) among nonusers. We observed no significant modification of VE by statin use. VE against influenza A(H1N1)pdm09, A(H3N2), and B viruses were similar among statin users and nonusers.

conclusionsIn this large observational study, influenza VE against laboratory-confirmed influenza illness was not affected by current statin use among persons aged ≥45 years. Statin use did not modify the effect of vaccination on influenza when analyzed by type and subtype.

Indexed as

Vaccine PotencyAgedFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsImmunologic FactorsInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza B virusInfluenza, HumanInfluenza VaccinesMaleMiddle AgedOdds RatioUnited StatesVaccinationHydroxymethylglutaryl-CoA Reductase InhibitorsImmunologic FactorsInfluenza Vaccinesinfluenza vaccinestatinsvaccine effectiveness

Identifiers

PMID30371753
PMCPMC6495015
OpenAlexW2898441436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.